Antimicrobial Resistance Multi-Partner Trust Fund 

Objectives

Fund scope

Applying best practices and scaling up joint action are central to countering antimicrobial resistance (AMR). The mis- and over-use of antimicrobial drugs in human and veterinary practices, and food production has placed our future at risk by increasing animal and human resistance to antibiotics. Because few solutions are currently available, we are hurtling towards a post-antibiotic era where common infections could kill millions and increase the risk of routine medical procedures.

In 2019, the Food and Agriculture Organization (FAO), World Organisation for Animal Health (OIE), and World Health Organization (WHO) joined forces to address the health risks of AMR with this pooled fund. Comprised of global/regional and national components, the Antimicrobial Resistance MPTF reduces the threat of AMR by funding transformative and innovative practices that support national governments in implementing and maintaining the ‘One Health’ approach.

Financial resources are used to pinpoint existing gaps and coordinate multi-sector responses for addressing AMR at regional and country levels

Theory of change and strategic framework

Tackling AMR through a collective ‘One Health’ approach can lead to the development robust, cost-effective and efficient solutions. It also contributes to reaching various Sustainable Development Goal health-security targets. Fund outcomes are to reduce and slow the development of AMR, maintain the ability to treat infectious diseases with effective and safe antimicrobial drugs, and to lessen the effect of AMR on humans, livestock, and animals.

To achieve results stakeholders focus on solutions geared towards effective sanitation and hygiene, improved research and surveillance, rethinking current use of antimicrobial drugs, and investing in new medicines, diagnostic tools, vaccines and alternatives to antibiotics. Adjacent to this will be designing and implementing national One Health Action Plans.

Country-led action, collaborative partnerships, immediate and longer-term strategies, increased data collection and analysis, and evidence-based comes are foundational principles of the Fund.

Image

GovernanceGovernance arrangements

Governance arrangements are based on standard practices for pass-through MPTFs and United Nations Sustainable Development Group best practices.

Steering Committee

The Antimicrobial Resistance MPTF Steering Committee is responsible for providing overall strategic guidance to the Fund. The Committee is composed of representatives from FAO, OIE, WHO, partners, the Multi-Partner Trust Fund (MPTF) Office. Meeting every six months, the Steering Committee is chaired by one of the founding organizations.

Antimicrobial Resistance MPTF Secretariat

The Secretariat supports the work of the Steering Committee, participating United Nations organizations, and the Administrative Agent, and monitors Fund operations. A dedicated Coordinator oversees Fund activities relating to coordination and acting as a liaison.

Participating Organizations

All Participating Organizations accept full financial and programmatic accountability for programmes developed (jointly or individually) in accordance with their regulations and approved programming cycles.

Administrative Agent

The MPTF Office acts as the Administrative Agent of the Fund, providing support and administrative services to participating organizations on behalf of the Antimicrobial Resistance MPTF, using a pass-through modality. Provided they meet the fiduciary and organizational requirements outlined in the memorandum of understanding and Terms of Reference, United Nations organizations are able to apply their own procedures.

Projects

Antimicrobial Resistance Multi-Partner Trust Fund

Antimicrobial Resistance Multi-Partner Trust Fund is currently supporting count_projects ongoing projectscount_globalInterregional and count_countries country-specific. This table shows the most recently approved ongoing projects.

All project financial information can be found in the Financials section, including delivery analysis by organization, theme and project; project financial status by country and by theme.

Antimicrobial Resistance Multi-Partner Trust Fund

ResultsFocus on impact and results

The Antimicrobial Resistance MPTF is a results-oriented and evidence-based Fund that reduces the threat of AMR by funding transformative and innovative practices that support national governments in implementing and maintaining the ‘One Health’ approach. Activities at all levels (global, regional, and national) will be monitored and evaluated against respective workplans, timelines, and frameworks.

In this section you will find the latest editions of reports that detail Fund performance and results. In most cases, results are presented according to SDG contributions, signature indicators, management procedures, and Fund outcomes.

ContactsPoints of contact

Policy and Programme 

Haile Getahun Gebre  Director, Global Coordination and Partnerships AMR WHO, Email: Getahunh@who.int
Keith Sumption Director of Business Development and Resource Mobilization FAO, Email: cvo@fao.org
Monserrat Arroyo, Deputy Director General for International Standards and Science, OIE, Email: m.arroyo@oie.int
Sheila Aggarwal-Khan, Director, Economy Division, UNEP, Email: sheila.aggarwal-khan@un.org
Mam Issa Mboob-Hunger, AMR MPTF Coordinator, Email: mboobm@who.int

Administrative Agent 

Olga Aleshina, Senior Portfolio Manager, Email: olga.aleshina@undp.org
Sillas Molosiwa, Portfolio Analyst, Email: sillas.molosiwa@undp.org
Anita Amissah-Arthur, Portfolio Associate, Email: anita.amissah-arthur@undp.org 
Patricia Ababio, Finance Associate, Email: patricia.ababio@undp.org